Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
158P1D7タンパク質に結合する抗体薬物結合体(ADC)
Document Type and Number:
Japanese Patent JP6426607
Kind Code:
B2
Abstract:
The invention provides an antibody-drug conjugate comprising an anti-158P1D7 antibody or antigen binding fragment thereof conjugated to monomethyl auristatin E (MMAE), wherein the antibody or fragment thereof comprises a heavy chain variable region comprising an amino acid sequence at least 80% homologous to the heavy chain variable region amino acid sequence set forth in SEQ ID NO:7 and a light chain variable region comprising an amino acid sequence at least 80% homologous to the light chain variable region amino acid sequence set forth in SEQ ID NO:8.

Inventors:
Morrison Robert Kendall
Anjiri
Morris Karen Jane Meyrick
Snyder Josh
Chia Xiao
Application Number:
JP2015528704A
Publication Date:
November 21, 2018
Filing Date:
August 23, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Agensis, Inc.
Seattle Genetics, Inc.
International Classes:
C07K19/00; A61K39/395; A61K45/00; A61K47/42; A61P35/00; A61P43/00; C07K16/18; C07K16/46; C12N5/10; C12N15/13; C12N15/63; C12P21/08
Domestic Patent References:
JP2007524361A
JP2007514652A
Foreign References:
US20030017466
US20030207835
US20030199470
Other References:
Molecular Cancer Therapeutics,2004年,Vol.3, No.8,p.921-932
Nature Biotechnology,2008年,Vol.26, No.8,p.925-932
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto